Cargando…
Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
Sodium–glucose cotransporter 2 (SGLT-2) inhibitors (i) reduce cardiovascular and renal events in patients with and without type 2 diabetes (T2D). However, the underlying mechanisms are debated. Low-grade inflammation (LGI) is a key driver of vascular complications, suggested to be attenuated by SGLT...
Autores principales: | La Grotta, Rosalba, de Candia, Paola, Olivieri, Fabiola, Matacchione, Giulia, Giuliani, Angelica, Rippo, Maria Rita, Tagliabue, Elena, Mancino, Monica, Rispoli, Francesca, Ferroni, Sabina, Berra, Cesare Celeste, Ceriello, Antonio, Prattichizzo, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064844/ https://www.ncbi.nlm.nih.gov/pubmed/35503137 http://dx.doi.org/10.1007/s00018-022-04289-z |
Ejemplares similares
-
Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms
por: La Grotta, Rosalba, et al.
Publicado: (2022) -
Extracellular vesicle-shuttled miRNAs: a critical appraisal of their potential as nano-diagnostics and nano-therapeutics in type 2 diabetes mellitus and its cardiovascular complications
por: Prattichizzo, Francesco, et al.
Publicado: (2021) -
Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages
por: Prattichizzo, Francesco, et al.
Publicado: (2017) -
Where Metabolism Meets Senescence: Focus on Endothelial Cells
por: Sabbatinelli, Jacopo, et al.
Publicado: (2019) -
Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes
por: Sabbatinelli, Jacopo, et al.
Publicado: (2022)